Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose colchicine in ST-elevation myocardial infarction
IRCT20231001059578N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Oct 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) and acute ST-segment elevation myocardial infarction (STEMI) comparing Colchicine with Placebo (2 arms). Primary endpoints: Functional class, Chest pain occurrence and 3 more. Started Oct 2023; status: completed.
02
Drugs
colchicine
03
Conditions
myocardial infarction (MI)acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on IRCT20231001059578N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231001059578N1.